• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

ANTIMICROBIAL ACTIVITY OF NISINPRODUCED BY LACTOCOCOCCUSLACTIS SUBSP. LACTIS AGAINST MULTI DRUG-RESISTANT ORAL PATHOGENS.

    Dr. Mukta Sharma

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 6714-6722

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The development and spread of pathogenic bacteria that are resistant to the existing catalog of antibiotics is a major public health threat. Biofilms are complex, sessile communities of bacteria embedded in an organic polymer matrix which serve to further enhance antimicrobial resistance. Consequently, novel compounds and innovative methods are urgently required to arrest the proliferation of drug-resistant infections. Nisin is a lantibiotic widely used for the preservation of food and beverages.Recently, investigators have,reported,that,nisin,may,have,clinical,applications,fortreatingbacterialinfections.TheaimofthisstudywastoinvestigatetheeffectsofNisinon multi drug resistant oral bacteria, isolated from human oral cavities.Chlorhexidine resistant Streptococcus mutans, penicillin resistant Streptococcus sanguinis and Streptococcus gordonii, tetracycline resistant Streptococcus mitis,,metronidazole,resistantLactobacillus,acidophilus,and,Actinomycesisraeliiwere,isolated,from,supragingigival,biofilms.Theminimuminhibitoryconcentrationsandminimumbactericidalconcentrationsoftaxonomicallydistinctoralbacteriaweredeterminedusing,agarandbrothdilutionmethods.Nisininhibitedplanktonicgrowthoforalbacteriaatlowconcentrations(2.5–50μg/ml).Accordingly, it has been suggested that antimicrobial peptides could be used as novel,natural,inhibitors,that,can,be,used,in,formulations,with,synergistically,acting,antibiotic.Thisworkhighlightsthepotentialtherapeuticvalueoffoodgradenisintoinhibitthegrowthoforalbacteriaandthedevelopmentofbiofimsrelevanttooraldiseases.
Keywords:
  • PDF (359 K)
  • XML
(2021). ANTIMICROBIAL ACTIVITY OF NISINPRODUCED BY LACTOCOCOCCUSLACTIS SUBSP. LACTIS AGAINST MULTI DRUG-RESISTANT ORAL PATHOGENS.. European Journal of Molecular & Clinical Medicine, 7(11), 6714-6722.
Dr. Mukta Sharma. "ANTIMICROBIAL ACTIVITY OF NISINPRODUCED BY LACTOCOCOCCUSLACTIS SUBSP. LACTIS AGAINST MULTI DRUG-RESISTANT ORAL PATHOGENS.". European Journal of Molecular & Clinical Medicine, 7, 11, 2021, 6714-6722.
(2021). 'ANTIMICROBIAL ACTIVITY OF NISINPRODUCED BY LACTOCOCOCCUSLACTIS SUBSP. LACTIS AGAINST MULTI DRUG-RESISTANT ORAL PATHOGENS.', European Journal of Molecular & Clinical Medicine, 7(11), pp. 6714-6722.
ANTIMICROBIAL ACTIVITY OF NISINPRODUCED BY LACTOCOCOCCUSLACTIS SUBSP. LACTIS AGAINST MULTI DRUG-RESISTANT ORAL PATHOGENS.. European Journal of Molecular & Clinical Medicine, 2021; 7(11): 6714-6722.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 37
  • PDF Download: 24
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus